Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells

Archives of Gynecology and Obstetrics

Volumn 284, Issue 6, 2011, Pages 1533-1541

  Zhao, Shuping ^a   Ma, Dehua ^a   Dai, Hongying ^a   Yuan, Fang ^a   Wang, Zenyan ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Endometrial neoplasm; Real time fluorescence quantitative RT PCR (FQ PCR); RNA interference (RNAi); Vascular endothelial growth factor (VEGF)

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; CYTOPATHOLOGY; ENDOMETRIUM CANCER; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; RNA INTERFERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; WESTERN BLOTTING; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; ENDOMETRIUM TUMOR; FEMALE; GENE SILENCING; GENETICS; HUMAN; METABOLISM; OLIGONUCLEOTIDE PROBE; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE SILENCING; HUMANS; OLIGONUCLEOTIDE PROBES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862592881     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1891-0     Document Type: Article

References (28)

1. Raymond CS, Zhu L, Vogt TF et al (2010) In vivo analysis of gene knockdown in tetracycline-inducible shRNA mice. Methods Enzymol 477:415-427
2. Grassmann R, Jeang KT (2008) The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta 1779(11):706-711
3. Yang H, Zhou H, Feng P et al. (2010) Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 29:92
4. Whipple C, Korc M (2008) Targeting angiogenesis in pancreatic cancer: rationale and pitfalls. Langenbecks Arch Surg 393(6):901-910
5. Hongying DAI, Ping Zhang, Shuping Zhao et al (2009) Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells. Oncol Rep 21:395-401
6. Grothey A, Galanis E (2009) Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 6(9):507-518
7. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25 (4):402-408 (Pubitemid 34164012)
8. Thurston G, Kitajewski J (2008) VEGF and Delta-Notch: interacting signaling pathways in tumor angiogenesis. Br J Cancer 99(8):1204-1209
9. Hervé MA, Meduri G, Petit FG et al (2006) Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol 188(1):91-99 (Pubitemid 43159813)
10. Wang FQ, Barfield E, Dutta S et al (2009) VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion. Gynecol Oncol 115(3):414-423
11. Harper SQ, Davidson BL (2005) Plasmid-based RNA interference: construction of small-hairpin RNA expression vectors. Methods Mol Biol 309:219-235
12. Phalon C, Rao DD, Nemunaitis J (2010) Potential use of RNA interference in cancer therapy. Expert Rev Mol Med. 18:12-26
13. Zhou J, Gan N, Zhang W et al (2010) Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor. J Obstet Gynaecol Res 36(2):232-238
14. Zhang L, Yang N, Mohamed-Hadley A et al (2003) Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun 303(4):1169-1178 (Pubitemid 36390268)
15. Holen T, Amarzguioui M, Wiiger MT et al (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nuclei Acids Res 30(8):1757-1766 (Pubitemid 34679753)
16. Wang X, Wang X, Varma RK et al (2009) Selection of hyperfunctional siRNAs with improved potency and specificity. Nucleic Acids Res 37(22):152
17. Phipps KM, Martinez A, Lu J et al (2004) Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism. Antivir Res 61(1):49-55 (Pubitemid 37508528)
18. Elbashir SM, Harborth W, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498 (Pubitemid 32494397)
19. Filleur S, Courtin A, Ait-Si-Ali S et al (2003) SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res 63(14):3919-3922 (Pubitemid 36917906)
20. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
21. Wright JD, Powell MA, Rader JS et al (2007) Bevacizumab therapy in patients with recurrent uterine neoplasms. Anticancer Res 27(5 B):3525-3528 (Pubitemid 47607497)
22. Wright JD, Viviano D, Powell MA et al (2006) Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer. Gynecol Oncol 103(2):489-493 (Pubitemid 44602157)
23. Kamat AA, Merritt WM, Coffey D et al (2007) Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res 13(24):7487-7495
24. Yin Y, Cao LY, Wu WQ et al (2010) Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. World J Gastroenterol 16(9):1086-1092
25. Adham SA, Sher I, Coomber BL (2010) Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells. Lab Invest 90(5):709-723
26. Höbel S, Koburger I, John M et al (2010) Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J Gene Med 12(3):287-300
27. Raskopf E, Vogt A, Sauerbruch T et al (2008) siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J Hepatol 49(6):977-984
28. Ma Z, Chow KM, Yao J et al (2004) Nuclear shuttling of the peptidase nardilysin. Arch Biochem Biophys 422(2):153-160 (Pubitemid 38169361)